SCHEMBL11888564

SCHEMBL11888564

COc1ccc(S(=O)(=O)C(CC(=O)Nc2ccccc2-c2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.65
PDE4B Q07343 5/20 0.65
PDE4C Q08493 5/20 0.65
PDE4D Q08499 5/20 0.65
ALDH1A1 P00352 6/20 0.63
SMN1; SMN2 Q16637 5/20 0.63
LMNA P02545 5/20 0.63
NPC1 O15118 4/20 0.63
MAPT P10636 4/20 0.63
RAB9A P51151 3/20 0.63
MMP2 P08253 3/20 0.61
MMP3 P08254 3/20 0.61
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
KMT2A Q03164 3/20 0.54
GAA P10253 2/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806438 0.77 SMN1; SMN2 (0.83) ALDH1A1SMN1; SMN2LMNAMAPTKMT2A
SCHEMBL6823156 0.76 MMP2 (1.00) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL12808152 0.75 ALDH1A1 (0.70) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL5702949 0.75 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DALDH1A1
Hydroxyamine SCHEMBL8164284 0.74 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL7207785 0.74 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL12808273 0.73 ALDH1A1 (0.67) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL806760 0.71 SMN1; SMN2 (0.75) SMN1; SMN2LMNAMAPTKMT2AGAA
SCHEMBL5703157 0.71 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL15617705 0.71 NPC1 (0.69) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9101635-B2 Inhibitors of filovirus entry into host cells MICROBIOTIX, INC. (US) 2015-08-11 US disclosed
US-20120189614-A1 INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS Crobiotix, Inc. (US) 2012-07-26 US disclosed
WO-2011046646-A2 INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS MICROBIOTIX, INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120189614-A1 INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS BSG, SLCO1B3, SLCO2B1 PDE4A 3993/4885PDE4B 4411/4885PDE4C 4562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.